• A Significant Contribution to Alzheimer’s Research from IBG
  • TÜBİTAK Support for IBG Therapeutic Bioengineering Laboratory Researchers
  • A New Biosensor Developed for Early Detection of Urinary Tract Infections
  • IBG-Biobank Team Awarded TÜBİTAK 1005 Research Project Funding
  • Five Projects by IBG Researchers Receive TÜBİTAK 1001 Funding
  • IBG-Biobank Submits ISO 20387 Accreditation Application
  • Two Strategic ERDARA Successes from IBG Targeting Rare Diseases
  • Scientific Output and Social Awareness Came to the fore at IBG Science Day 2025
  • ANTİKAD Honors IBG Principal Investigator with the “2025 Academic of the Year” Award
  • IBG Science Day 2025
Drug Analysis and Control Lab. (GLP) Drug Analysis and Control Lab. (GLP)
Nevcell (GMP) Nevcell (GMP)
Pharma Pharma
Vivarium Vivarium
Biomedical Device and Technology Development Biomedical Device and Technology Development
Biobank Biobank

Izmir Biomedicine and Genome Center

İBG officially started operations in January 2018 as Turkey’s first Thematic Research Center under Law No. 6550.

The mission of İBG is to develop innovative technologies and products for the prevention, diagnosis, and treatment of diseases, using basic research in life sciences as a driving force.


About Us

News

A Significant Contribution to Alzheimer’s Research from IBG

18 February 2026 A Significant Contribution to Alzheimer’s Research from IBG

TÜBİTAK Support for IBG Therapeutic Bioengineering Laboratory Researchers

10 February 2026 TÜBİTAK Support for IBG Therapeutic Bioengineering Laboratory Researchers

A New Biosensor Developed for Early Detection of Urinary Tract Infections

27 January 2026 A New Biosensor Developed for Early Detection of Urinary Tract Infections

IBG-Biobank Team Awarded TÜBİTAK 1005 Research Project Funding

26 January 2026 IBG-Biobank Team Awarded TÜBİTAK 1005 Research Project Funding